In vitro experimental model | Experimental conditions | |||
---|---|---|---|---|
Model system | Unstimulated (“Ctr”) | 106/mL N. meningitidis (“Nm”) | 106/mL N. meningitidis + 25 ng/mL IL-10 (“Nm + IL-10”) | 25 ng/mL IL-10 (“IL-10”)a |
Patient plasma system | Plasma from patients with meningococcal meningitis or mild meningococcemia (“low LPS plasma”) | Plasma from patients with severe meningococcal sepsis or septic shock, depleted for IL-10 (“IL-10 immunodepleted plasma”) | Plasma from patients with severe meningococcal sepsis or septic shock (“patient plasma with IL-10”) | Plasma from patients with meningococcal meningitis or mild meningococcemia, depleted for IL-10 (“low LPS plasma immunodepleted for IL-10”)a |